SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome -- Ignore unavailable to you. Want to Upgrade?

To: Cheeseburger who wrote (698)6/9/1999 8:11:00 PM
From: AL PELLICCIO  Respond to of 900
 
Cheeseburger, same report in Dick Davis digest. The heading :
A BIOTECH ABOUT TO BLOOM. Sure looks strong the last few days. later Al



To: Cheeseburger who wrote (698)6/9/1999 8:57:00 PM
From: Alan Rosen  Read Replies (2) | Respond to of 900
 
Cheese,

Thanks for sharing that with the rest of the thread. Received the S&P report with my Fidelity statement a few days ago, I didn't post because I mistakenly thought that someone beat me to it. This bodes well for stock IMHO.

archcc



To: Cheeseburger who wrote (698)7/1/1999 5:52:00 PM
From: Ed  Read Replies (1) | Respond to of 900
 
LIPO was mentioned again in last weeks S&P Outlook. They had a piece about Wallflowers, good stocks that could move up with better coverage. Another currently hot biotech, Enzon, was also on the list.
It said that LIPO is only covered by 4 companies and has about 23% institutional ownership. Enzon had coverage by 5 and 40% ownership.
Ed


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News